167 related articles for article (PubMed ID: 36436091)
21. Effects of the Pandemic on the Care of Patients With Colorectal Cancer.
Reinacher-Schick A; Ebert MP; Piso P; Hüppe D; Schmitt J; Schildmann J
Dtsch Arztebl Int; 2023 Aug; 120(33-34):545-552. PubMed ID: 37427989
[TBL] [Abstract][Full Text] [Related]
22. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
[TBL] [Abstract][Full Text] [Related]
23. Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study.
Bähler C; Brüngger B; Ulyte A; Schwenkglenks M; von Wyl V; Dressel H; Gruebner O; Wei W; Blozik E
BMC Public Health; 2021 Jan; 21(1):23. PubMed ID: 33402140
[TBL] [Abstract][Full Text] [Related]
24. [Outpatient pediatric care during the COVID-19 pandemic with special emphasis on screening examinations and immunizations].
Mangiapane S; Zhu L; Schulz M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Dec; 64(12):1551-1558. PubMed ID: 34713309
[TBL] [Abstract][Full Text] [Related]
25. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
[TBL] [Abstract][Full Text] [Related]
26. 10-year prevalence of diagnostic and screening colonoscopy use in Germany: a claims data analysis.
Hornschuch M; Schwarz S; Haug U
Eur J Cancer Prev; 2022 Nov; 31(6):497-504. PubMed ID: 34983895
[TBL] [Abstract][Full Text] [Related]
27. Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.
Anastasiadou Z; Schäfer I; Siebert J; Günther W; Reusch M; Augustin M
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):424-7. PubMed ID: 26856813
[TBL] [Abstract][Full Text] [Related]
28. Cancer screenings during the COVID-19 pandemic: An analysis of public interest trends.
Greiner B; Tipton S; Nelson B; Hartwell M
Curr Probl Cancer; 2022 Feb; 46(1):100766. PubMed ID: 34304883
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
30. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
31. [Effects of the Covid-19 Pandemic on Online Use of Video Consultation by General Practitioners in Germany - a Secondary Data Analysis of German Health Insurance Data].
Petrick N; Kreuzenbeck CCJ
Gesundheitswesen; 2023 Mar; 85(3):188-192. PubMed ID: 36693392
[TBL] [Abstract][Full Text] [Related]
32. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
[TBL] [Abstract][Full Text] [Related]
33. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
Tscheulin DK; Drevs F
Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
[TBL] [Abstract][Full Text] [Related]
34. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
[TBL] [Abstract][Full Text] [Related]
35. Trajectories and individual determinants of regular cancer screening use over a long period based on data from the French E3N cohort.
Dugord C; Franc C
Soc Sci Med; 2022 Feb; 294():114663. PubMed ID: 34974385
[TBL] [Abstract][Full Text] [Related]
36. Modifications in Primary Care Clinics to Continue Colorectal Cancer Screening Promotion During the COVID-19 Pandemic.
Arena L; Soloe C; Schlueter D; Ferriola-Bruckenstein K; DeGroff A; Tangka F; Hoover S; Melillo S; Subramanian S
J Community Health; 2023 Feb; 48(1):113-126. PubMed ID: 36308666
[TBL] [Abstract][Full Text] [Related]
37. Molecular-based Alternatives for Colorectal Cancer Screening during the COVID-19 Pandemic.
Dockter AG; Angelos GC
Surg Technol Int; 2020 May; 36():143-147. PubMed ID: 32347964
[TBL] [Abstract][Full Text] [Related]
38. Health Insurance Coverage Mandates: Colorectal Cancer Screening in the Post-ACA Era.
Preston MA; Ross L; Chukmaitov A; Smith SA; Odlum ML; Dahman B; Sheppard VB
Cancer Prev Res (Phila); 2021 Jan; 14(1):123-130. PubMed ID: 32917646
[TBL] [Abstract][Full Text] [Related]
39. Determinants of colorectal cancer screening in Germany: a claims data analysis.
Pardey N; Kreis K; Schmidt T; Stahmeyer JT; Krauth C; Zeidler J
Z Gastroenterol; 2021 Jul; 59(7):644-656. PubMed ID: 34171930
[TBL] [Abstract][Full Text] [Related]
40. Determinants of Postponed Cancer Screening During the COVID-19 Pandemic: Evidence from the Nationally Representative COVID-19 Snapshot Monitoring in Germany (COSMO).
Hajek A; De Bock F; Huebl L; Kretzler B; König HH
Risk Manag Healthc Policy; 2021; 14():3003-3011. PubMed ID: 34285614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
